These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 11949825)
1. Progesterone receptor, bc1-2 and bax expression in meningiomas. Verheijen FM; Donker GH; Viera CS; Sprong M; Jacobs HM; Blaauw G; Thijssen JH; Blankenstein MA J Neurooncol; 2002 Jan; 56(1):35-41. PubMed ID: 11949825 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Takei H; Buckleair LW; Powell SZ Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195 [TBL] [Abstract][Full Text] [Related]
3. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882 [TBL] [Abstract][Full Text] [Related]
4. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Blankenstein MA; Verheijen FM; Jacobs JM; Donker TH; van Duijnhoven MW; Thijssen JH Steroids; 2000; 65(10-11):795-800. PubMed ID: 11108890 [TBL] [Abstract][Full Text] [Related]
5. Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Blankenstein MA; van der Meulen-Dijk C; Thijssen JH Clin Chim Acta; 1987 Jun; 165(2-3):189-95. PubMed ID: 3308181 [TBL] [Abstract][Full Text] [Related]
6. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147 [TBL] [Abstract][Full Text] [Related]
7. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437 [TBL] [Abstract][Full Text] [Related]
8. Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. Maiuri F; De Caro MB; Esposito F; Cappabianca P; Strazzullo V; Pettinato G; de Divitiis E J Neurooncol; 2007 Mar; 82(1):63-8. PubMed ID: 17225937 [TBL] [Abstract][Full Text] [Related]
9. Progestin and estrogen receptors in human meningioma. Blankenstein MA; Blaauw G; Lamberts SW Clin Neuropharmacol; 1984; 7(4):363-7. PubMed ID: 6509448 [TBL] [Abstract][Full Text] [Related]
10. Alteration of bcl-2 and bax expression in embolized meningiomas. Nakasu S; Nakajima M; Nakazawa T; Nakasu Y; Handa J Brain Tumor Pathol; 1998; 15(1):13-7. PubMed ID: 9879458 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III. Fonseca-Moutinho JA; Cruz E; Carvalho L; Prazeres HJ; de Lacerda MM; da Silva DP; Mota F; de Oliveira CF Int J Gynecol Cancer; 2004; 14(5):911-20. PubMed ID: 15361203 [TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor synthesis in human meningiomas: relation to the estrogen-induced proteins pS2 and cathepsin-D and influence of epidermal growth factor, Forskolin and phorbol ester in vitro. Koehorst SG; Spapens ME; Van Der Kallen CJ; Van 'T Verlaat JW; Blaauw G; Thijssen JH; Blankenstein MA Int J Biol Markers; 1998; 13(1):16-23. PubMed ID: 9681295 [TBL] [Abstract][Full Text] [Related]
13. Progesterone and estrogen receptors in meningiomas: prognostic considerations. Hsu DW; Efird JT; Hedley-Whyte ET J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089 [TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor isoform expression in human meningiomas. Verheijen FM; Sprong M; Jacobs HM; Donker GH; Amelink GJ; Thijssen JH; Blankenstein MA Eur J Cancer; 2001 Aug; 37(12):1488-95. PubMed ID: 11506955 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315 [TBL] [Abstract][Full Text] [Related]
16. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164 [TBL] [Abstract][Full Text] [Related]
17. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast. Magro G; Bisceglia M; Michal M Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093 [TBL] [Abstract][Full Text] [Related]
18. Progesterone and oestrogen receptors in meningiomas: biochemical and clinicopathological considerations. Whittle IR; Foo MS; Besser M; Vanderfield GK Aust N Z J Surg; 1984 Aug; 54(4):325-30. PubMed ID: 6593026 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Khalid H Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047 [TBL] [Abstract][Full Text] [Related]
20. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]